Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Intra-coronary Infusion of Bone Marrow Derived Autologous CD34+ Selected Cells in Patients With Acute Myocardial Infarction (AMR-1)

This study has been completed.
Texas Heart Institute
Information provided by (Responsible Party):
Arshed A. Quyyumi, Emory University Identifier:
First received: April 10, 2006
Last updated: November 15, 2013
Last verified: November 2013